These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2149292)

  • 1. Interactions of spironolactone with (+)-[3H]-isradipine and (-)-[3H]-desmethoxyverapamil binding sites in vascular smooth muscle.
    Mironneau J; Sayet I; Rakotoarisoa L; Dacquet C; Mironneau C
    Br J Pharmacol; 1990 Sep; 101(1):6-7. PubMed ID: 2149292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.
    Rakotoarisoa L; Sayet I; Mironneau C; Mironneau J
    J Pharmacol Exp Ther; 1990 Dec; 255(3):942-7. PubMed ID: 2175807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+)-[3H]-PN 200-110 binding to cell membranes and intact strips of portal vein smooth muscle: characterization and modulation by membrane potential and divalent cations.
    Dacquet C; Loirand G; Rakotoarisoa L; Mironneau C; Mironneau J
    Br J Pharmacol; 1989 May; 97(1):256-62. PubMed ID: 2524235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of binding of 3H-desmethoxyverapamil and 3H-mibefradil in vascular smooth muscle and heart membranes. Possible binding of mibefradil to a site distinct from the phenylalkylamine-binding site.
    Ratner EI; Bochkov VN; Tkachuk VA
    Arzneimittelforschung; 1996 Oct; 46(10):953-5. PubMed ID: 8931886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmethoxyverapamil-sensitive calcium channels in rat portal vein smooth muscle.
    Loirand G; Dacquet C; Pacaud P; Rakotoarisoa L; Sayet I; Mironneau C; Mironneau J
    Eur J Pharmacol; 1989 Aug; 167(2):265-74. PubMed ID: 2556285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of [3H]isradipine (PN 200-110) on smooth muscle cell membranes from different bovine arteries.
    Pinquier JL; Urien S; Chaumet-Riffaud P; Comte A; Tillement JP
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):402-6. PubMed ID: 2453742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channels: basic properties as revealed by radioligand binding studies.
    Glossmann H; Ferry DR; Goll A; Striessnig J; Schober M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S20-30. PubMed ID: 2414589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oxodipine and elgodipine on (+)-[3H]-isradipine binding to cardiac and vascular membranes: cardiovascular selectivity.
    Rakotoarisoa L; Leprêtre N; Mironneau J; Galiano A; Mironneau C
    Fundam Clin Pharmacol; 1994; 8(6):546-52. PubMed ID: 7721232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of [3H]dihydropyridine binding by activation of protein kinase C in vascular smooth muscle.
    Mironneau C; Rakotoarisoa L; Sayet I; Mironneau J
    Eur J Pharmacol; 1991 Nov; 208(3):223-30. PubMed ID: 1663046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.
    Feron O; Wibo M; Christen MO; Godfraind T
    Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanine nucleotide-binding proteins modulate desmethoxyverapamil binding to calcium channels in vascular smooth muscle.
    Rakotoarisoa L; Mironneau C; Sayet I; Mironneau J
    J Pharmacol Exp Ther; 1991 Oct; 259(1):164-8. PubMed ID: 1656017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and distribution of three prototype calcium channel blockers in perfused rat liver.
    Bikhazi AB; Bitar KM; Kreydiyyeh SI; Saleh RS; el-Kasti MM; Ibrahim MZ; Abu Khoudoud OR
    Mol Cell Biochem; 1997 Apr; 169(1-2):1-11. PubMed ID: 9089625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of high affinity phenylalkylamine binding sites on cultured human embryonal vascular smooth muscle cells.
    Drímal J
    Gen Physiol Biophys; 1992 Dec; 11(6):555-65. PubMed ID: 1338048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel.
    Shimasue K; Urushidani T; Hagiwara M; Nagao T
    Eur J Pharmacol; 1996 Feb; 296(3):347-50. PubMed ID: 8904088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites.
    Ferry DR; Goll A; Gadow C; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):183-7. PubMed ID: 6092974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine.
    Morel N; Godfraind T
    Br J Pharmacol; 1991 Feb; 102(2):467-77. PubMed ID: 1826619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
    Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
    FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel antagonist effects of spironolactone, an aldosterone antagonist.
    Mironneau J
    Am J Cardiol; 1990 Jun; 65(23):7K-8K; discussion 3K. PubMed ID: 2162139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
    Quast U; Bray KM; Andres H; Manley PW; Baumlin Y; Dosogne J
    Mol Pharmacol; 1993 Mar; 43(3):474-81. PubMed ID: 8450836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.